Why mindfulness practices don’t move seamlessly across cultures.
Thursday, December 18, 2025
Does the Fate of Ivermectin As a Covid-19 Treatment Rest in the Hands of the Deeply Conflicted Bill & Melinda Gates Foundation?
One of the world’s biggest vaccine proponents and strident defender of intellectual property rights is funding, directly and indirectly, large trials into cheap, off-patent, off-label COVID-19 treatments, including ivermectin.
America’s Afghan War Is Over, So What About Iraq – and Iran?
America is finally out of one unwinnable war. How does this bode for the US extracting itself from other Middle Eastern quagmires?
Michael Hudson Discusses Financialization, Rentierism, and Other Favorite Topics with Jessi Ora of Swedish Positiva Pengar Group
Michael Hudson gives another wide-ranging, tour de force interview. Enjoy!
2:00PM Water Cooler 7/12/2021
~ Today’s Water Cooler ~
Steve Wozniak Endorses the Right to Repair
Last week, President Joe Biden and Apple co-founder Steve Wozniak endorsed the right to repair.
‘Wake Up Call’: Rapidly Thawing Permafrost Threatens Trans-Alaska Pipeline
Thawing permafrost is undermining the supports that hold up an elevated section of the Trans-Alaska Pipeline, putting in danger the structural integrity of one of the world’s largest oil pipelines.
Kentucky Retirement System Litigation Against KKR, Blackstone, PAAMCO et. al. Takes New Class Action/Civil RICO Twist
Those pesky lawyers behind Mayberry v. KKR won’t give up! And some private equity titans are likely plenty unhappy about that.
Understanding the Opioid Epidemic: When Innovation Fails, or Rather Works Too Well
The opioid crisis provides a deadly example of why innovation often is simply a new-fangled form of predation.
Purdue Bankruptcy Plan Moves Closer to Approval: Sacklers Would Make Out Well and Preserve Much of the Family Fortune, Despite the Opioids Crisis
Last week fifteen states dropped opposition to Purdue Pharma’s bankruptcy exit plan, making it likely the plan will be approved when it comes before a federal bankruptcy judge in August.
Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The largest drug companies are far more interested in enriching themselves and investors than in developing new drugs, according to a House committee report released Thursday
